Skip to main content
logo
Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.455
+0.075 (5.43%)
Aug 21, 2026, 11:28 AM EDT - Market open

Dermata Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-8.37-7.56-12.29-7.79-9.61-7.9
Other Amortization
-----0.01
Stock-Based Compensation
0.150.140.660.520.931.91
Change in Accounts Payable
0.7-0.39-0.110.37-0.020.41
Change in Other Net Operating Assets
-0.370.050.580.49-0.14-0.12
Operating Cash Flow
-8.03-7.76-11.16-6.41-8.83-5.69
Operating Cash Flow Growth
------

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----1.56
Total Debt Issued
-----1.56
Long-Term Debt Repaid
------0.56
Net Debt Issued (Repaid)
-----1.01
Issuance of Common Stock
6.1712.176.897.614.2815.39
Repurchase of Common Stock
-0-0-0-0--
Other Financing Activities
-0.09-0.05----
Financing Cash Flow
6.0812.126.897.614.2815.96

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-2.074.36-4.281.2-4.5610.27

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-5.11-5.02-6.65-3.64-5.59-2.49
Unlevered Free Cash Flow
-5.11-5.02-6.65-3.64-5.59-2.48

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-----0
Cash Income Tax Paid
000000
Change in Working Capital
0.18-0.340.470.86-0.150.29
SEC Filings: 10-K · 10-Q